TPG and Blackstone, two prominent private equity firms, are in discussions to sell the surgical division of Hologic, a medtech company they recently acquired. This potential sale is expected to exceed $4 billion, according to sources from the Financial Times.
The surgical unit of Hologic has garnered interest due to its significant market position and the ongoing demand for innovative medical technologies.
In addition to the sale, PSG's backing of BrightAnalytics highlights the strategic moves within the private equity landscape, as firms seek to capitalize on lucrative opportunities in the healthcare sector.